Coherus Biosciences | CHRS - SCHULD

Aktienkurs
1.65
Täglich Wechseln
-0.01 -0.60%
Monatlich
0%
Jährlich
96.76%
Q1 Prognose
1.72




SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 71.6M 1.08M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
Amgen USD 54.59B 1.62B 2025-09
Baxter International USD 9.71B 13M 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.51B 2.6B 2025-09
Fujifilm JPY 922.82B 236.91B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Merck USD 41.37B 5.97B 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Xencor USD 69.27M 1.34M 2025-09
Zoetis USD 7.27B 482M 2025-09